Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy

Background: In the current Japanese aging society, a high number of very elderly patients (age ranged from 80 to 93) with diffuse large B-cell lymphoma (DLBCL, most frequent hematological malignancy), who require chemotherapy are encountered. However, standard chemotherapy can result in severe adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Hiroto, Shimura, Kazuho, Yoshida, Mihoko, Matsumoto, Yosuke, Kobayashi, Tsutomu, Uchiyama, Hitoji, Kuroda, Junya, Taniwaki, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339123/
https://www.ncbi.nlm.nih.gov/pubmed/35975118
http://dx.doi.org/10.18502/ijhoscr.v16i1.8433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339123/
https://www.ncbi.nlm.nih.gov/pubmed/35975118
http://dx.doi.org/10.18502/ijhoscr.v16i1.8433

Ejemplares similares